Precision Oncology Strategy in Trastuzumab-Resistant Human Epidermal Growth Factor Receptor 2–Positive Colon Cancer: Case Report of Durable Response to Ado-Trastuzumab Emtansine ...
Drugs targeting mutations in the anaplastic lymphoma kinase gene (ALK) are already useful in lung cancer, but they may also find a use in the treatment of leukemias. ALK mutations were found in two ...
There is an urgent need for innovative therapeutic options that impact disease progression after failure with standard of care, ALK tyrosine kinase inhibitor therapies TRI-611 is an oral ...
The case study, which showed prolonged disease control achieved with gilteritinib in a previously-treated patient with AML with an inv(2)(p23q13) translocation, indicates that gilteritinib can also be ...
There are many treatment options for lung cancer, but the right one for you will depend on many factors including the type of lung cancer you have. Non-small-cell lung cancer (NSCLC) is the most ...
North America includes (Canada, Mexico, USA) Europe includes (Germany, France, Great Britain, Italy, Spain, Russia) Asia-Pacific includes (China, Japan, India, South Korea, Australia) Middle East and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results